A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors
  • Events
  • Panel discussion: Jayasree K. Iyer to address Prescription for...
Panel discussion - Event date: 30 Oct 2018

Jayasree K. Iyer to address Prescription for Progress: the essential role of partnerships in strengthening health systems

On Tuesday October 30, Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, will speak at the Prescription for Progress: the essential role of partnerships in strengthening health systems. The event, organised by the Devex, will convene 100 influential stakeholders including researchers, technologists, investors, donors, NGO leaders, and more. It is designed to address the practical hurdles associated with bringing global health innovations to scale and strengthening health systems.

Jayasree will participate in a panel discussion themed Taking global health work from silos to systems: How might we align incentives across sectors? Drawing from the findings of the Access to Medicine Index, she will present examples of successful business models and programmes implemented by pharmaceutical companies to improve access to medicine in low- and middle-income countries.

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |